Surgery Partners, Inc.
SGRY
$21.48
-$0.36-1.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10,750.00% | -546.94% | -182.01% | 50.20% | 95.73% |
| Total Depreciation and Amortization | 9.00% | 73.70% | 42.62% | 0.00% | 5.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 121.49% | 27.38% | 113.57% | 5.16% | 8.51% |
| Change in Net Operating Assets | 52.05% | -229.36% | 30.65% | -430.70% | 26.59% |
| Cash from Operations | 77.96% | -37.67% | 58.93% | -45.37% | 769.44% |
| Capital Expenditure | -12.63% | -6.88% | -4.26% | 13.58% | 12.78% |
| Sale of Property, Plant, and Equipment | -- | 100.00% | -100.00% | -81.25% | -100.00% |
| Cash Acquisitions | -180.77% | -401.89% | -7,400.00% | -34.15% | 51.10% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 59.15% | -154.55% | 88.14% | 34.31% | -607.14% |
| Cash from Investing | -92.25% | -93.75% | -242.84% | -17.54% | 19.53% |
| Total Debt Issued | -62.40% | 81.27% | 10,304.72% | 1,110.69% | 324.49% |
| Total Debt Repaid | 75.64% | -78.57% | -5,371.79% | -655.97% | 10.31% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.49% | -7.96% | -35.68% | 1.46% | 31.75% |
| Cash from Financing | 207.62% | 64.22% | 486.94% | 176.94% | -123.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 218.95% | -85.84% | 141.56% | 71.39% | -131.30% |